Method for treating pneumocystis carinii pneumonia patients with

Details Method for treating pneumocystis carinii pneumonia patients with Method for treating pneumocystis carinii pneumonia patients with

1987-08-20

1989-05-30

Bell, Mark L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514310, A61K 3170, A61K 3171

Patent

active

048351407

ABSTRACT:
The combination of clindamycin and primaquine or pharmaceutical salts thereof is effective in treating patients with Pneumocystis carinii pneumonia.

REFERENCES:
patent: 3856943 (1974-12-01), Birkenmeyer
patent: 4293547 (1981-10-01), Lewis et al.
patent: 4368193 (1983-01-01), Argondelts et al.
patent: 4746651 (1988-05-01), Goodman
Physicians Desk Reference, Charles Baker, Jr.; Publisher, 1977, 31st Edition, pp. 1616 and 1701.
Hughes, W. T., et al., Antimicrobial Agents and Chemotherapy 5:289-293 (1974).
Hughes, W. T. and Smith, B. L., Antimicrobial Agents and Chemotherapy 26:436-440 (1984).
Perez, G., et al., Abstracts of Annual Meeting of American Society for Microbiology, 79 (1985).
Schmidt, L. H., Antimicrobial Agents and Chemotherapy 27:151-157 (1985).
Toshida, T., Medical Journal of Hiroshima University, Paper, 385-398.

Affiliated with

Also associated with

Rating

Method for treating pneumocystis carinii pneumonia patients with does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating pneumocystis carinii pneumonia patients with, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating pneumocystis carinii pneumonia patients with will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2152676